Medicenna Therapeutics Co... (MDNA)
Medicenna Therapeutics Statistics
Share Statistics
Medicenna Therapeutics has 0 shares outstanding. The number of shares has increased by 0% in one year.
| n/a |
| 0% |
| 0% |
| n/a |
| n/a |
| 6,796 |
| 0.54% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is 35.63 and the forward PE ratio is null. Medicenna Therapeutics's PEG ratio is -0.34.
| 35.63 |
| n/a |
| 0 |
| n/a |
| 1.87 |
| -4.35 |
| -0.34 |
Enterprise Valuation
Medicenna Therapeutics has an Enterprise Value (EV) of 21.52M.
| 0 |
| -1.32 |
| -1.7 |
| -1.7 |
Financial Position
The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.
| 9.57 |
| 9.57 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is 5.25% and Return on Invested Capital is 7.69%.
| 5.25% |
| 4.24% |
| 7.69% |
| n/a |
| $96,687.5 |
| 16 |
| 0 |
| n/a |
Taxes
| -11.6M |
| 115.4% |
Stock Price Statistics
The stock price has increased by -56.16% in the last 52 weeks. The beta is 0.77, so Medicenna Therapeutics's price volatility has been higher than the market average.
| 0.77 |
| -56.16% |
| 0.29 |
| 0.48 |
| 33.89 |
| 1,255,845 |
Balance Sheet
The company has 33.6M in cash and 0 in debt, giving a net cash position of 33.6M.
| 33.6M |
| n/a |
| n/a |
| -80.98M |
| 27.74M |
| 23.99M |
Cash Flow
In the last 12 months, operating cash flow was -12.66M and capital expenditures 0, giving a free cash flow of -12.66M.
| -12.66M |
| n/a |
| -12.66M |
| -0.2 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
MDNA does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 2.81% |
| -22.96% |
Analyst Forecast
The average price target for MDNA is $2.5, which is 1462.5% higher than the current price. The consensus rating is "Buy".
| $2.5 |
| 1462.5% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -4.13 |
| 1 |